Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1825217 | 0.97 | PTGS1 (0.41) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL4300905 | 0.84 | APP (0.44) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL424022 | 0.84 | APP (0.44) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Water SCHEMBL429998 | 0.82 | APP (0.42) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL395722 | 0.81 | APP (0.46) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL29462018 | 0.79 | APP (0.44) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| Hydrochloric Acid SCHEMBL5070335 | 0.79 | APP (0.44) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL2187038 | 0.77 | APP (0.42) | PTGS1PDE4ALMNASLC6A6CYP2C19 | |
| SCHEMBL6723728 | 0.73 | APEX1 (0.30) | — | |
| SCHEMBL920488 | 0.71 | PTGS1 (0.56) | PTGS1PDE4ALMNASLC6A6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3565017-B1 | ELECTROCHEMICAL LIGHT EMITTING CELL | JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECH (JP) | 2022-07-20 | — | — | EP | disclosed |
| CN-110121795-B | Electrochemical light-emitting cell | 国立大学法人北陆先端科学技术大学院大学 | 2021-09-24 | — | — | CN | disclosed |
| CN-107532100-B | Lubricant comprising silicon-containing ionic liquid | 日清纺控股株式会社 | 2020-10-02 | — | — | CN | disclosed |
| EP-3296381-B1 | LUBRICANT INCLUDING SILICON-CONTAINING IONIC LIQUID | NISSHINBO HOLDINGS INC (JP) | 2020-07-15 | — | — | EP | disclosed |
| US-10658700-B2 | Additive for electrolyte solutions | NISSHINBO HOLDINGS INC. (JP) | 2020-05-19 | — | — | US | disclosed |
| US-10619117-B2 | Lubricant including silicon-containing ionic liquid | NISSHINBO HOLDINGS INC. (JP) | 2020-04-14 | — | — | US | disclosed |
| EP-3565017-A1 | ELECTROCHEMICAL LIGHT EMITTING CELL | Japan Advanced Institute of Science and Technology (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-20190316738-A1 | LIGHT-EMITTING ELECTROCHEMICAL CELL | NISSHINBO HOLDINGS INC. (JP) | 2019-10-17 | — | — | US | disclosed |
| US-20180269529-A1 | ADDITIVE FOR ELECTROLYTE SOLUTIONS | NISSHINBO HOLDINGS INC. (JP) | 2018-09-20 | — | — | US | disclosed |
| EP-2910558-B1 | IONIC LIQUID | NISSHINBO HOLDINGS INC (JP) | 2018-08-08 | — | — | EP | disclosed |
| WO-2007008472-A2 | PHOTOINDUCED SIGNAL AMPLIFICATION THROUGH EXTERNALLY SENSITIZED PHOTOFRAGMENTATION IN MASKED PHOTOSENSITIZERS | COLORADO SEMINARY, WHICH OWNS AND OPERATES THE UNIVERSITY OF DENVER (US) | 2007-01-18 | — | — | WO | disclosed |
| EP-1730137-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | Bristol-Myers Squibb Company (US) | 2006-12-13 | — | — | EP | disclosed |
| EP-1689493-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Pharma Company (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005095383-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050215576-A1 | Novel therapeutic agents for the treatment of migraine | BRISTOL-MYERS SQUIBB COMPANY | 2005-09-29 | — | — | US | disclosed |
| WO-2005065779-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-07-21 | — | — | WO | disclosed |
| EP-1539766-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20040204397-A1 | Calcitonin gene related peptide receptor antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-14 | — | — | US | disclosed |
| US-20040063735-A1 | Calcitonin gene related peptide receptor antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2004-04-01 | — | — | US | disclosed |
| WO-2003104236-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063735-A1 | Calcitonin gene related peptide receptor antagonists | CALCRL, CALCA, CALCR | PTGS1 63/4885PDE4A 1537/4885LMNA 2724/4885 |
| US-20050215576-A1 | Novel therapeutic agents for the treatment of migraine | CALCRL, CALCR, CALCA | PTGS1 94/4885PDE4A 707/4885LMNA 3181/4885 |
| US-10619117-B2 | Lubricant including silicon-containing ionic liquid | MUC1, CCR1, TAS1R1 | PTGS1 2279/4885PDE4A 4836/4885LMNA 3650/4885 |
| US-20040204397-A1 | Calcitonin gene related peptide receptor antagonists | CALCRL, CALCA, CALCR | PTGS1 63/4885PDE4A 1537/4885LMNA 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.